EU approval for Teva's quarterly dosed migraine drug
Teva Canada announces the launch of AJOVY™ for the preventive treatment of migraine in adults who have at least four migraine days per month
Ajovy, Teva's migraine drug, recommended by UK's NICE.
E | WikiKenko - Health Encyclopedia
Teva Announces Ministry of Health, Labour and Welfare Approves AJOVY® (fremanezumab) Injection in Japan for the Preventive Treatment of Migraine in Adults | Business Wire
PDF) Migraine therapeutics differentially modulate the CGRP pathway
Teva to acquire Labrys Biologics, Inc.: Novel migraine prophylaxis treatment adds significant new dimension to Teva's growing pain care franchise - Drug Target Review